These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7685459)
1. [Therapeutic alternatives in benign prostatic hyperplasia]. Isa Kroon WA; Robles García JE Med Clin (Barc); 1993 Jun; 101(2):64-6. PubMed ID: 7685459 [No Abstract] [Full Text] [Related]
2. Benign prostatic hyperplasia. Barry M; Roehrborn C Clin Evid; 2002 Jun; (7):775-87. PubMed ID: 12230703 [No Abstract] [Full Text] [Related]
3. Benign prostatic hyperplasia. Barry M; Roehrborn C; Webber R Clin Evid; 2002 Dec; (8):849-63. PubMed ID: 12603916 [No Abstract] [Full Text] [Related]
4. Transurethral resection of the prostate: still the gold standard? Ramsey EW Can J Surg; 1993 Feb; 36(1):9-10. PubMed ID: 7680274 [No Abstract] [Full Text] [Related]
5. [Current state of the surgical treatment of benign prostatic hypertrophy]. Pagano F J Urol (Paris); 1993; 99(6):362-3. PubMed ID: 7516392 [No Abstract] [Full Text] [Related]
6. [Non surgical treatment of benign prostatic hypertrophy]. Martini E; Vaggi L; Rucci A; Di Clemente L J Urol (Paris); 1993; 99(6):278-82. PubMed ID: 7516366 [No Abstract] [Full Text] [Related]
7. Treatment options for benign prostatic hyperplasia. Portis AJ; Mador DR Can Fam Physician; 1997 Aug; 43():1395-404. PubMed ID: 9266125 [TBL] [Abstract][Full Text] [Related]
8. Optimising the medical management of benign prostatic hyperplasia. McDermott T Br J Clin Pract; 1997 Mar; 51(2):116-8. PubMed ID: 9158256 [TBL] [Abstract][Full Text] [Related]
9. [Current role of cryosurgery in benign prostatic hypertrophy compared to recent minimally invasive methods]. Rigondet G; Salé JM; Claude R Ann Urol (Paris); 1992; 26(3):155-66. PubMed ID: 1381165 [TBL] [Abstract][Full Text] [Related]
10. What will replace TURP? Brawer MK; McConnell JD; Oesterling JE Contemp Urol; 1992 Feb; 4(2):30-40. PubMed ID: 10151029 [TBL] [Abstract][Full Text] [Related]
11. [Alternatives to transurethral resection of benign hypertrophy of the prostate]. Vicente Rodríguez J Arch Esp Urol; 1991; 44(1):1-7. PubMed ID: 1712185 [No Abstract] [Full Text] [Related]
12. Alternative therapy for benign prostatic hypertrophy. Tung KH Singapore Med J; 1994 Aug; 35(4):347-8. PubMed ID: 7534943 [No Abstract] [Full Text] [Related]
13. Benign prostatic hyperplasia. Current strategy and pharmacotherapeutical potential. Dutkiewicz S Mater Med Pol; 1995; 27(1):3-6. PubMed ID: 8569274 [No Abstract] [Full Text] [Related]
14. Current issues and reported findings from the National Survey on Benign Prostatic Hyperplasia. Fawzy A Int J Clin Pract Suppl; 2001 Sep; (122):2-22. PubMed ID: 11695085 [No Abstract] [Full Text] [Related]
15. Benign prostatic hyperplasia--review of treatment options. Oehlke KJ; Branaugh ML S D Med; 2009 May; 62(5):202-3. PubMed ID: 19489345 [No Abstract] [Full Text] [Related]
16. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia. DiSantostefano RL; Biddle AK; Lavelle JP BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339 [TBL] [Abstract][Full Text] [Related]
17. Finasteride in benign prostatic hyperplasia. Verhamme KM; Bosch RJ; Sturkenboom MC N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034 [No Abstract] [Full Text] [Related]
18. Benign prostatic hyperplasia. New concepts in the 1990s. Moul JW Postgrad Med; 1993 Nov; 94(6):141-6, 151-2. PubMed ID: 7694269 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological options in the treatment of benign prostatic hyperplasia. Kenny B; Ballard S; Blagg J; Fox D J Med Chem; 1997 Apr; 40(9):1293-315. PubMed ID: 9135028 [No Abstract] [Full Text] [Related]